Voltammetric Study and Direct Analytical Determination of the Antiparkinson Drug Benserazide

For the first time, a simple differential pulse voltammetry methodology for direct determination of benserazide in presence of levodopa in tablets was developed without any redox mediator, modified electrodes, or the aplication of mathematic deconvolution of signals. Benserazide was studied by differential pulse voltammetry using glassy carbon electrode in aqueous media. The drug exhibited a main well-defined oxidation signal in a broad pH range (2–10), and two poorly resolved signals at higher potentials. We have found that levodopa does not interfere on the electrochemical response of benserazide at pH 6.0. Thus, at this pH value, the developed analytical method exhibited adequate repeatability and reproducibility (RSD < 2%), recoveries >98.5%, which permitted its successful application to both the assay and the uniformity content of benserazide. Also, hydrolytic degradation studies of benserazide were carried out by differential pulse voltammetry.     

Simultaneous Spectrophotometric Determination of Levodopa and Benserazide in a Pharmaceutical

ABSTRACT

A method based on a partial least-squares calibration (PLS) for the simultaneous spectrophotometric determination of levodopa (I) and benserazide (II) in a commercially available pharmaceutical preparation is proposed. The calibration procedure was developped by using laboratory made mixtures of I and II, and optimized by selecting the most suitable wavelength range and spectral mode. The relative standard error of prediction (RSEP %) was 0.5% and 0.9% with a limiting reproducibility (R) of 4 10^?6 M and 1.5 10^?6 M for levodopa and benserazide, respectively The proposed method is straightforward, expeditious and precise. Its results are consistent with those provided by HPLC for the two analytes.     

Simultaneous voltammetric determination of levodopa, carbidopa and benserazide in pharmaceuticals using multivariate calibration

An analytical methodology based on differential pulse voltammetry (DPV) on a glassy carbon electrode and the partial least-squares (PLS-1) algorithm for the simultaneous determination of levodopa, carbidopa and benserazide in pharmaceutical formulations was developed and validated. Some sources of bi-linearity deviation for electrochemical data are discussed and analyzed. The multivariate model was developed as a ternary calibration model and it was built and validated with an independent set of drug mixtures in presence of excipients, according with manufacturer specifications. The proposed method was applied to both the assay and the uniformity content of two commercial formulations containing mixtures of levodopa-carbidopa (10:1) and levodopa-benserazide (4:1). The results were satisfactory and statistically comparable to those obtained by applying the reference Pharmacopoeia method based on high performance liquid chromatography. In conclusion, the methodology proposed based on DPV data processed with the PLS-1 algorithm was able to quantify simultaneously levodopa, carbidopa and benserazide in its pharmaceuticals formulations using a ternary calibration model for these drugs in presence of excipients. Furthermore, the model appears to be successful even in the presence of slight potential shifts in the processed data, which have been taken into account by the flexible chemometric PLS-1 approach.     

基于纳米结构的电化学传感器用于伏安法测定苄丝肼、尿酸和叶酸(英文)

A carbon paste electrode modified with carbon nanotubes and ferrocene was fabricated.An electrochemical study of the modified electrode and an investigation into its efficiency for the electrocatalytic oxidation of benserazide,uric acid and folic acid were undertaken.The electrode was also used to study the electrocatalytic oxidation of benserazide using cyclic voltammetry,chronoamperometry,and square wave voltammetry(SWV).We found that the oxidation of benserazide at the surface of the modified electrode occurs at a potential about 285 mV lower than that of unmodified carbon paste electrode.SWV gave a linear dynamic range from 8.0×10-7 to 7.0×10 4 mol/L.The detection limit was 1.0×10-7 mol/L for benserazide.This modified electrode was used for the determination of benserazide,uric acid,and folic acid in an urine sample.     

Capillary electrophoresis-chemiluminecence detection of levodopa and benserazide in Medopar tablet

A novel method for the simultaneous determination of benserazide and levodopa using capillary electrophoresis(CE)- chemiluminescence(CL)has been developed.Under the optimal conditions,the detection limits(S/N=3)were 1.85μg/mL for benserazide and 0.12μg/mL for levodopa.This method was successfully applied to the determination of benserazide and levodopa in Medopar tablet,the results showed that the detected values are in accordance with those by official methods.     

Application of silver nanoparticles and principal component-artificial neural network models for simultaneous determination of levodopa and benserazide hydrochloride by a kinetic spectrophotometric method

A multicomponent analysis method based on principal component analysis-artificial neural network model (PC-ANN) is proposed for the simultaneous determination of levodopa (LD) and benserazide hydrochloride (BH). The method is based on the reaction of levodopa and benserazide hydrochloride with silver nitrate as an oxidizing agent in the presence of PVP and formation of silver nanoparticles. The reaction monitored at analytical wavelength 440 nm related to surface plasmon resonance band of silver nanoparticles. Differences in the kinetic behavior of the levodopa and benserazide hydrochloride were exploited by using principal component analysis, an artificial neural network (PC-ANN) to resolve concentration of analytes in their mixture. After reducing the number of kinetic data using principal component analysis, an artificial neural network consisting of three layers of nodes was trained by applying a back-propagation learning rule. The optimized ANN allows the simultaneous determination of analytes in mixtures with relative standard errors of prediction in the region of 4.5 and 6.3 for levodopa and benserazide hydrochloride respectively. The results show that this method is an efficient method for prediction of these analytes.     

Determination of Levodopa and Benserazide Hydrochloride in Pharmaceutical Formulations by CZE with Amperometric Detection

A novel method, capillary electrophoresis with amperometric detection, has been established for rapid and effective measurement of levodopa (L-dopa), and benserazide (BS) and its impurity (R,S)-2-amino-3-hydroxypropanohydrazide (Ro-04-1419) in co-beneldopa pharmaceutical formulations. Suitable separation and amperometric detection conditions were investigated and optimized. The optimum conditions of CZE detection were 40 mm phosphate solution at pH 5.3 as running buffer, 17 kV separation voltage, carbon-disk working electrode, 0.95 V (relative to Ag/AgCl) as detection potential, and sample injection for 8 s at 17 kV. The linear ranges were from 1.25 to 50 g mL^–1 for L-dopa, 1.2 × 10^–1 to 25.5 g mL^–1 for BS, and 1.0 × 10^–2 to 4.4 × 10^–1 g mL^–1 for Ro-04-1419, with correlation coefficients of 0.9994, 0.9951, and 0.9933, respectively. The detection limits for L-dopa, BS, and Ro-04-1419 were 0.38, 0.02, and 0.004 g mL^–1, respectively. Average recoveries were 100.2% for L-dopa, 102.4% for BS, and 90.8% for Ro-04-1419. This method was successfully applied to co-beneldopa granules and tablets.Revised: 30 November and 22 December 2004